However, in combination with Decitabine [109,112,113,124] and also with Cytarabine [111], Venetoclax [114] or the STAT5 inhibitor AC-4-130 [27], it showed promising results and increased AML treatment efficacy. The gene discussed is STAT5B; the disease is acute myeloid leukemia.